The advertisement promotes Cosentyx, an IL-17 antagonist medication, highlighting its approval for two maintenance dosing options and providing important safety information and contraindications.
Creative Information
| CID: | 24e27480-549b-44fa-a86b-24547f113425 |
| CRID: | 82_5530-801205 |
| Domain: | cosentyx.com |
| Seat: | PP |
| Size: | 728x90 |
| Bid: | $35.27 |
| Timestamp: | 11/7/2025, 2:47:16 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/7/2025, 5:33:17 PM | 5.94s | |
| adomain_analysis | success | 11/7/2025, 7:58:45 PM | 3.94s | |
| adomain_capture | success | 11/7/2025, 7:58:41 PM | 0.18s | |
| ad_render | success | 11/7/2025, 5:33:11 PM | 23.93s | |
| brand_mapping | success | 11/7/2025, 2:47:16 PM | 0.10s | |
Analysis Results
Ad Format: banner
Brands: Cosentyx
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1045.70 KB | ||||||||||||||||||||||
| Render Time: | 8.50 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1066.88 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

